Anti-metastatic marine bacterial exopolysaccharide derivative and uses thereof
US11219638B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 28, 2016 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Sep 28, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a low-molecular-weight (15 kDa) over-sulfated exopolysaccharide (GYS15) prepared from a marine native exopolysaccharide excreted by a mesophilic marine bacterium from a deep-sea hydrothermal environment, and relates to the use of this low-molecular-weight over-sulfated exopolysaccharide for the prevention or inhibition of metastases formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.